Lenalidomide Mylan

Medicinal product

(Invented) name

Lenalidomide Mylan

Active substance (s)

Lenalidomidas

Strength

2,5 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L04AX04, Lenalidomide

Marketing authorisation holder

Mylan Pharmaceuticals Limited, Airija

Date of authorisation

2020-12-18

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Capsule, hard	1 vnt.
Lenalidomidas	2,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
105601	91701	1091701	lizdinė plokštelė	N7		Receptinis	EU/1/20/1490/001	Netiekiama	-	-	No	-	-
105602	91702	1091702	lizdinė plokštelė	N21		Receptinis	EU/1/20/1490/002	Netiekiama	-	-	No	-	-
105603	91703	1091703	dalomoji lizdinė plokštelė	N21×1		Receptinis	EU/1/20/1490/003	Netiekiama	-	-	No	-	-
106913	93016	1093016	dalomoji lizdinė plokštelė	N7×1		Receptinis	EU/1/20/1490/019	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2020-12-18	Registruotas